ANDA 205791, held by Perrigo R And D. Sildenafil Citrate.
As of Nov 15, 2026, ANDA 205791 (Sildenafil Citrate), held by Perrigo R And D, was first approved by FDA on Apr 23, 2020, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 23, 2020 | Original application | Approved | None posted |
| Sildenafil CitrateEQ 25MG BASE · tablet;oral | Sildenafil Citrate | Discontinued |
| Sildenafil CitrateEQ 50MG BASE · tablet;oral | Sildenafil Citrate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
